Medical Research News

RSS

Study reveals why women with PCOS struggle to maintain healthy habits

A recent study in the Journal of Nutrition Education and Behavior (JNEB), published by Elsevier, provides new insight into how women with polycystic ovary syndrome (PCOS) adopt and maintain healthy eating and physical activity behaviors.

24 Sep 2026

Rising prescription and supplement use poses health risks for seniors

Older Americans are increasingly taking multiple prescription medications and dietary supplements. Although the prevalence of potentially major drug-drug interactions has declined slightly, more than 1 in 5 older adults are potentially at risk, according to a USC-led study published September 24 in JAMA.

24 Sep 2026

Childhood adversity strongly linked to poor mental health in young adults

Emerging adults with an average age of 19 who experienced four or more adverse childhood experiences had substantially higher rates of depression, suicidal ideation, hard drug use, and interpersonal violence than those who reported no childhood adversity.

24 Sep 2026

Mount Sinai researchers discover how Alzheimer's gene damages blood vessels

Mount Sinai researchers have identified how APOE4, the strongest genetic risk factor for Alzheimer's disease, damages the brain's blood vessels and promotes the buildup of abnormal proteins linked to neurodegenerative disease.

24 Sep 2026

Multiple immunosuppressive therapies increase infection risks for cancer patients

Retrospective analysis of more than 20,000 patient records identifies opportunities for risk-mitigating approaches in certain patient populations.

24 Sep 2026

Scientists uncover molecular mechanism that tunes eye light sensitivity

Weill Cornell Medicine investigators have determined the mechanism by which a molecule within cells can help tune the light sensitivity of the eyes.

24 Sep 2026

Five research teams secure funding for frontotemporal dementia studies

The Kissick Family Foundation, in partnership with the Milken Institute Science Philanthropy's Accelerator for Research and Collaboration (SPARC), today announced five research teams selected to receive a total of $2.5 million through the third funding cycle of the Kissick Family Foundation Frontotemporal Dementia (FTD) Grant Program.

24 Sep 2026

Chronic stress and social support affect how cognitive abilities change with age

Chronic stress and perceived social support may play a role in how memory and thinking abilities change with age, according to a new study led by researchers at Wake Forest University School of Medicine.

24 Sep 2026

Cornell study reveals hidden nutritional trade-offs in healthy food labels

A new analysis of nearly 150,000 food and beverage products launched in the United States over the past decade, found that products bearing health-related claims are not only not consistently healthier, they are sometimes less nutritious.

24 Sep 2026

Kidney rhythm mismatch linked to dangerous nighttime high blood pressure

Most people's blood pressure falls by 10 to 20 per cent while they sleep, giving the heart and blood vessels a chance to recover. But for some people, that nighttime dip never happens.

24 Sep 2026

Community gathering venues reduce long-term care costs for vulnerable seniors

Community gathering places are intended to facilitate exercise and social participation for all residents, irrespective of functional decline status.

24 Sep 2026

Scientists discover the molecular mechanism behind instantaneous memory formation

The National Institute of Information and Communications Technology (NICT, President: OHNO Hideo, Ph.D.) has discovered molecular mechanism of synaptic facilitation, instantaneous strengthening of synaptic transmission, which may be physiological basis of instantaneous memory.

24 Sep 2026

Athletes struggle to recognize subtle signs of coach sexual abuse

A study carried out by GIKAFIT group of the EHU-University of the Basque Country shows that more than 80% of the athletes identify the more explicit behaviors but not other, more normalized, forms of interaction.

24 Sep 2026

Less is more: Exercise rivals common pain meds

From osteoarthritis to a splitting migraine, when you’re experiencing pain, exercise can seem like the last thing you want or think you should do. But according to new Adelaide University research it could be one of the most effective ways to help ease your symptoms.

24 Sep 2026

Engineered nanoparticles sensitize gliomas to radiotherapy

Gliomas are a major cause of cancer-related deaths in younger adults.

24 Sep 2026

GLP-1s linked to nutritional deficiencies in children

Children prescribed GLP-1 medications for weight loss, prediabetes, or type 2 diabetes are at risk for nutritional deficiencies – diagnosed in nearly one in six patients (16.8%) within the first year – according to a new study published in the journal Childhood Obesity.

24 Sep 2026

From lab to living room: Revolutionary Utah bionic arm enters first home trial

At age 16, Alexander “Avi” Davidson fell 35 feet from the top of a telephone pole, an accident that left him paralyzed from the waist down and led to the amputation of his left arm below the elbow.

24 Sep 2026

As GLP-1 drugs become more complex, their effects on the heart are getting harder to predict

A brief report reviews emerging GLP-1 receptor co-agonists that also target GIPR, GCGR, and other receptors, examining their metabolic benefits alongside known and predicted cardiac effects. The authors highlight substantial species differences, warning that mouse heart studies may fail to predict responses in human cardiac tissue and that many proposed cardiac effects still require direct testing.

24 Sep 2026

GLP-1 drugs may influence chronic pain through gut-brain and immune pathways

Researchers reviewed evidence linking GLP-1 and GLP-1 receptor agonists to chronic pain modulation through gut microbial, neuroimmune, vagal, and metabolic pathways, with the strongest clinical evidence currently involving knee osteoarthritis and idiopathic intracranial hypertension headache. Much of the proposed biology remains supported by preclinical research, and human studies have yet to establish that GLP-1RA-induced changes in the gut microbiome directly cause pain relief.

24 Sep 2026

Advances in chemistry and delivery are taking oligonucleotide medicines beyond rare diseases

A review in Cell Reports Medicine examines how advances in oligonucleotide chemistry and delivery have established ASOs and RNA interference therapies as a class of genetic medicines, with 21 oligonucleotides approved at the time of writing. It also identifies extrahepatic delivery, safety, target validation, individualized treatment, and data quality as priorities as the field expands into common diseases and explores AI-assisted development.

24 Sep 2026